These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3313982)

  • 1. Cyclosporine A-related nephrotoxicity after cardiac transplantation: the role of plasma renin activity.
    Schüler S; Thomas D; Hetzer R
    Transplant Proc; 1987 Oct; 19(5):3998-4001. PubMed ID: 3313982
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinants of cyclosporine nephrotoxicity following cardiac transplantation.
    Martin M; Packham D; Kingswood C; Cairns H; Khaghani A; Thompson D; Yacoub M
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2516-7. PubMed ID: 3274553
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine dose adjustment in patients with normal serum creatinine and trough levels: a challenge for successful long-term treatment.
    Cantarovich F; Cantarovich D; Touraine JL; Tizado J; Castro LZ; Correa C; Herman AP; Traeger J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):402-6. PubMed ID: 3284084
    [No Abstract]   [Full Text] [Related]  

  • 4. An update on the use of low-dose maintenance cyclosporine A therapy after renal transplantation.
    Karmi SA; DePalma R; Bosch J; Dosa S; Michell A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):110-3. PubMed ID: 3291218
    [No Abstract]   [Full Text] [Related]  

  • 5. Is cyclosporine-associated nephrotoxicity progressive?
    Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
    Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992
    [No Abstract]   [Full Text] [Related]  

  • 6. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 7. De novo accelerated hypertension during sequential cyclosporine and prednisone therapy in normotensive bone marrow transplant recipients.
    Textor SC; Forman SJ; Bravo EL; Carlson J
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):480-6. PubMed ID: 3291284
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of cyclosporine toxicity by reduced dosage and azathioprine.
    Griffith BP; Hardesty RL; Lee A; Trento A; Thompson ME; Shapiro AP; Bahnson HT
    J Heart Transplant; 1985; 4(4):410-3. PubMed ID: 3916516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between blood pressure and renin, angiotensin II and atrial natriuretic factor after renal transplantation.
    Hestin D; Mertes PM; Hubert J; Claudon M; Mejat E; Renoult E; Pertek JP; Frimat L; Burlet C; Kessler M
    Clin Nephrol; 1997 Aug; 48(2):98-103. PubMed ID: 9285146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute cyclosporine A nephrotoxicity in rats: which role for renin-angiotensin system and glomerular prostaglandins?
    Perico N; Benigni A; Bosco E; Rossini M; Orisio S; Ghilardi F; Piccinelli A; Remuzzi G
    Clin Nephrol; 1986; 25 Suppl 1():S83-8. PubMed ID: 3519031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine nephrotoxicity in orthotopic liver transplantation.
    Gonwa TA; Poplawski SC; Husberg BS; Nery JR; Klintmalm GB
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):401-4. PubMed ID: 3291276
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroendocrine response to cardiac transplantation.
    Masters RG; Davies RA; Keon WJ; Walley VM; Koshal A; de Bold AJ
    Can J Cardiol; 1993 Sep; 9(7):609-17. PubMed ID: 8221359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclosporine on renal function following orthotopic heart transplantation.
    McKenzie N; Keown P; Stiller C; Kostuk W; Campbell C; Keith F
    J Heart Transplant; 1985; 4(4):400-3. PubMed ID: 3916514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine related hypertension and nephrotoxicity in rat heart transplantation.
    Kanehira A; Shida T; Nakamura H; Wakita N; Ito H; Nakamura K
    Dev Toxicol Environ Sci; 1986; 14():141-7. PubMed ID: 3549246
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine maintenance therapy in psoriasis.
    Meinardi MM; Bos JD
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):42-9. PubMed ID: 3381301
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients.
    Bantle JP; Nath KA; Sutherland DE; Najarian JS; Ferris TF
    Arch Intern Med; 1985 Mar; 145(3):505-8. PubMed ID: 3883934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective serial renal function studies in patients with nonrenal disease treated with cyclosporine A.
    Tegzess AM; Doorenbos BM; Minderhoud JM; Donker AJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):530-3. PubMed ID: 3388497
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
    Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C
    J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved immunosuppression for heart transplantation.
    Bolman RM; Elick B; Olivari MT; Ring WS; Arentzen CE
    J Heart Transplant; 1985 May; 4(3):315-8. PubMed ID: 3916502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cyclosporine by constant-rate intravenous infusion immediately after heart transplantation.
    Myre SA; Schroeder TJ; Melvin DB; Clardy CW; Pesce AJ; Wadhwa NK; Collins JA; Wolf RK; Brown LL; Stephens GW
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):316-22. PubMed ID: 3291262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.